Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-throughput single-cell profiling of B cell responses following inactivated influenza vaccination in young and older adults. | Aging (Albany NY) | 2023 | 37367734 | PubTator, text mining | PubMed |
| Viral recognition and the antiviral interferon response. | EMBO J | 2023 | 37367474 | PubTator, text mining | PubMed |
| Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review. | Strahlenther Onkol | 2023 | 37347290 | PubTator, text mining | PubMed |
| 3D genome organization and epigenetic regulation in autoimmune diseases. | Front Immunol | 2023 | 37346038 | PubTator, text mining | PubMed |
| The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness. | Neurologia (Engl Ed) | 2023 | 37344097 | PubTator, text mining | PubMed |
| TRIM21 restricts influenza A virus replication by ubiquitination-dependent degradation of M1. | PLoS Pathog | 2023 | 37343022 | PubTator, text mining | PubMed |
| Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts. | Front Immunol | 2023 | 37342322 | PubTator, text mining | PubMed |
| Prognostic and clinicopathological significance of TRIM21 in various cancers: A meta and bioinformatic analysis. | Medicine (Baltimore) | 2023 | 37335642 | PubTator, text mining | PubMed |
| FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury. | Cell Death Dis | 2023 | 37330523 | PubTator, text mining | PubMed |
| Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? | Front Immunol | 2023 | 37325634 | PubTator, text mining | PubMed |
Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report. | Front Med (Lausanne) | 2023 | 37324147 | PubTator, text mining | PubMed |
| Rejection of Lepeophtheirus salmonis driven in part by chitin sensing is not impacted by seawater acclimitization in Coho salmon (Oncorhynchus kisutch). | Sci Rep | 2023 | 37322246 | PubTator, text mining | PubMed |
| Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironment. | Sci Rep | 2023 | 37322027 | PubTator, text mining | PubMed |
| Bifidobacterium longum and Chlorella sorokiniana Improve the IFN Type I-Mediated Antiviral Response in Rotavirus-Infected Cells. | Microorganisms | 2023 | 37317211 | PubTator, text mining | PubMed |
| Rift Valley fever virus modulates apoptosis and immune response during infection of human astrocytes. | Emerg Microbes Infect | 2023 | 37306630 | PubTator, text mining | PubMed |
| Sex and gender influence on immunity and autoimmunity. | Front Immunol | 2023 | 37304263 | PubTator, text mining | PubMed |
| Unraveling the potential of 3D bioprinted immunomodulatory materials for regulating macrophage polarization: State-of-the-art in bone and associated tissue regeneration. | Bioact Mater | 2023 | 37303852 | PubTator, text mining | PubMed |
| Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction. | BMC Cancer | 2023 | 37296415 | PubTator, text mining | PubMed |
| Indoleamine 2,3-dioxygenase 1 regulates cell permissivity to astrovirus infection. | Mucosal Immunol | 2023 | 37290501 | PubTator, text mining | PubMed |
| High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome. | Front Immunol | 2023 | 37275905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=22